ZLDPFZealand Pharma A/S

About Zealand Pharma A/S (ZLDPF)

Zealand Pharma A/S (ZLDPF) is a Biotechnology company headquartered in Glostrup, Denmark whose shares trade over-the-counter on the Pink tier.

Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other specialty disease areas with significant unmet medical needs. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim.

ZLDPF key facts

Ticker symbol

ZLDPF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Glostrup, Denmark

Estimated market cap

$1.92B (as of Apr 11, 2025)

Shares outstanding

30,750,000

Reporting standard

International Reporting: BME Spanish Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with Z